| Business Summary | | Gum
Tech
International
Inc.
researches,
develops,
manufactures,
markets
and
distributes
products
in
the
nutrient
and
drug
delivery
systems
market.
The
Company's
current
operations
are
divided
into
two
primary
groups:
Zicam
Operations
and
Gum
Operations.
Through
a
joint
venture
with
Zensano
Inc.,
a
subsidiary
of
Zengen,
Inc.,
the
Company
is
engaged
in
the
manufacture,
marketing,
and
distribution
of
health-related
products
using
a
patented
nasal
gel
technology.
The
initial
product
marketed
by
this
joint
venture
and
introduced
in
1999
was
Zicam
Cold
Remedy,
a
homeopathic,
nasal
gel
product
that
has
been
formulated
to
reduce
the
severity
and
duration
of
the
common
cold.
The
Company
develops
and
manufactures
specialty
chewing
gum
products
for
branded
and
private
label
customers,
as
well
as
products
marketed
under
the
Company's
own
brand. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | GUMM
researches,
develops,
manufactures,
markets
and
distributes
products
in
the
nutrient
and
drug
delivery
systems
market.
For
the
three
months
ended
3/31/01,
revenues
increased
77%
to
$7.1
million.
Net
loss
applicable
to
Common
decreased
78%
to
$590
thousand.
Revenues
reflect
increased
sales
of
Zicam
Cold
Remedy
due
to
customer
awareness
and
acceptance
of
the
product.
Lower
losses
also
reflect
decreased
advertising
expenses
and
interest
expense. Recent Earnings Announcement For
the
3
months
ended
06/30/2001,
revenues
were
1,373;
after
tax
earnings
were
-1,934. (Preliminary; reported in thousands of dollars.) | More
from
Market Guide: Significant
Developments |
| | | | FY2000
Compensation | | Pay | Exer | |
| Edward Faber, 68 Chairman | -- | -- | Carl Johnson Pres, Director | -- | -- | William Hemelt, 47 CFO,
Exec. VP - Operations, Sec., Treasurer | $103K | $54K | Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|